Maze Therapeutics (MAZE) Interest Coverage Ratio (2026)

Maze Therapeutics has reported Interest Coverage Ratio for 3 years, with the latest figure at 7.09 in Q1 2026.

• Quarterly Interest Coverage Ratio changed N/A year-over-year to 7.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 35.78 (changed N/A YoY) and the FY2025 annual result came in at 0.87, down 233.77% from the prior year.
• Interest Coverage Ratio advanced to 7.09 in Q1 2026 per MAZE's latest filing, from 0.34 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 7.09 in Q1 2026 and troughed at 60.17 in Q4 2024.
• A 3-year average of 17.81 and a median of 0.34 in 2025 frame the typical range for Interest Coverage Ratio.
• The widest YoY moves for Interest Coverage Ratio: up 99.44% in 2025, down 99.44% in 2025.
• Over 3 years, Interest Coverage Ratio stood at 60.17 in 2024, then soared by 99.44% to 0.34 in 2025, then soared by 2185.96% to 7.09 in 2026.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 7.09, 0.34, and 60.17 for Q1 2026, Q4 2025, and Q4 2024 respectively.